Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court

The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage

Anlon Healthcare gets Brickwork rating withdrawal after facility closure

This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities

Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker

Fischer Medical converts warrants into equity, infuses Rs 10.53 crore

Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure

Sun Pharma appoints former PwC India COO Satyavati Berera as independent director

Board approves five-year appointment, subject to shareholder nod through postal ballot

Max Healthcare allots 57,461 equity shares under ESOP 2022

Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees

Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies

Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy

SAI Parenteral's acquires Australia's Noumed Pharmaceuticals for Rs. 125 Cr

Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma

Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040

Briefs: Nectar Lifesciences, Cipla and Marksans Pharma

Marksans Pharma gets USFDA nod for acid reflux drug